(HealthDay)—Sulfonylureas as second-line drugs for type 2 diabetes are associated with an increased risk of cardiovascular and hypoglycemic events compared
Continue reading »Home »
Can stress testing and biomarker studies predict cardiovascular event risk in older women?
Mayo Clinic researchers, reporting results of the SMART study, have shown that abnormal results on a stress electrocardiogram are an
Continue reading »